[1] |
Kutlubay Z, Sevim Keçici A, Çelik U, et al. A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow⁃up[J]. Turk J Med Sci, 2021,51(1):124⁃133. doi: 10.3906/sag⁃2006⁃231.
|
[2] |
Amber KT, Murrell DF, Schmidt E, et al. Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management[J]. Clin Rev Allergy Immunol, 2018,54(1):26⁃51. doi: 10.1007/s12016⁃017⁃8633⁃4.
|
[3] |
王思航, 左亚刚. 2021版法国大疱性类天疱疮治疗指南解读[J]. 中国医学科学院学报, 2022,44(5):828⁃836. doi: 10.3881/j.issn.1000⁃503X.14912.
|
[4] |
Zuo YG, Lin L, Chen JB, et al. Chinese expert proposal on the diagnosis and management of pemphigus vulgaris (2020)[J]. Int J Dermatol Venerol, 2020,3(3):148⁃155. doi: 10.1097/JD9. 0000000000000088.
|
[5] |
Morin C, Fardet L. Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross⁃sectional online survey of 820 patients[J]. Clin Rheumatol, 2015,34(12):2119⁃2126. doi: 10.1007/s10067⁃015⁃2953⁃7.
|
[6] |
Ferri M, Ranucci E, Romagnoli P, et al. Antimicrobial resistance: a global emerging threat to public health systems[J]. Crit Rev Food Sci Nutr, 2017,57(13):2857⁃2876. doi: 10.1080/10408398.2015.1077192.
|
[7] |
van Duin D, Paterson DL. Multidrug⁃resistant bacteria in the community: an update[J]. Infect Dis Clin North Am, 2020,34(4):709⁃722. doi: 10.1016/j.idc.2020.08.002.
|
[8] |
Miodovnik M, Künstner A, Langan EA, et al. A distinct cutaneous microbiota profile in autoimmune bullous disease patients[J]. Exp Dermatol, 2017,26(12):1221⁃1227. doi: 10. 1111/exd.13357.
|
[9] |
Humphries R, Bobenchik AM, Hindler JA, et al. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st edition[J]. J Clin Microbiol, 2021,59(12):e0021321. doi: 10.1128/JCM.00213⁃21.
|
[10] |
谢朝云, 闫飞, 熊永发, 等. 骨科开放伤口多重耐药菌感染危险因素的Logistic回归分析[J]. 中国矫形外科杂志, 2017,25(2):108⁃113. doi: 10.3977/j.issn.1005⁃8478.2017.02.03
|
[11] |
李小磊, 芦永华, 黄新玲, 等. 糖尿病足溃疡病原菌分布及多重耐药菌感染的危险因素[J]. 中国感染控制杂志, 2018,17(8):708⁃712. doi: 10.3969/j.issn.1671⁃9638.2018.08.011.
|
[12] |
李扬威, 温景祥, 曲健源, 等.表皮葡萄球菌的临床分布及耐药性分析[J].检验医学与临床, 2023,20(17):2599⁃2602. doi: 10.3969/j.issn.1672⁃9455.2023.17.033.
|
[13] |
Zhang H, Yang Q, Liao K, et al. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra⁃abdominal infection patients[J]. BMC Infect Dis, 2017,17(1):776. doi: 10.1186/s12879⁃017⁃2873⁃z.
|
[14] |
Sowole L, Ming DK, Davies F. Multidrug⁃resistant bacteria[J]. Br J Hosp Med (Lond), 2018,79(5):C66⁃C69. doi: 10.12968/hmed.2018.79.5.C66.
|
[15] |
Huscher D, Thiele K, Gromnica⁃Ihle E, et al. Dose⁃related patterns of glucocorticoid⁃induced side effects[J]. Ann Rheum Dis, 2009,68(7):1119⁃1124. doi: 10.1136/ard.2008.092163.
|
[16] |
Rzany B, Partscht K, Jung M, et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age[J]. Arch Dermatol, 2002,138(7):903⁃908. doi: 10.1001/archderm. 138.7.903.
|
[17] |
张春歌, 唐婕, 陈蓉. 风湿免疫科门诊长期口服糖皮质激素患者服药依从性现状研究及其药学干预[J]. 中国医院药学杂志, 2019,39(24):2558⁃2564. doi: 10.13286/j.cnki.chinhosppharmacyj. 2019.24.19.
|
[18] |
Lam WY, Fresco P. Medication adherence measures: an overview[J]. Biomed Res Int, 2015:217047. doi: 10.1155/2015/217047.
|
[19] |
Esmaili N, Chams⁃Davatchi C, Valikhani M, et al. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid⁃sparing agent[J]. Eur J Dermatol, 2008,18(2):159⁃164. doi: 10. 1684/ejd.2008.0354.
|
[20] |
Baskan EB, Yilmaz M, Tunali S, et al. Efficacy and safety of long⁃term mycophenolate sodium therapy in pemphigus vulgaris[J]. J Eur Acad Dermatol Venereol, 2009,23(12):1432⁃1434. doi: 10.1111/j.1468⁃3083.2009.03226.x.
|
[21] |
Zwerner J, Fiorentino D. Mycophenolate mofetil[J]. Dermatol Ther, 2007,20(4):229⁃238. doi: 10.1111/j.1529⁃8019.2007.00 136.x.
|
[22] |
Perez F, Van Duin D. Carbapenem⁃resistant Enterobacteriaceae: a menace to our most vulnerable patients[J]. Cleve Clin J Med, 2013,80(4):225⁃233. doi: 10.3949/ccjm.80a.12182.
|
[23] |
Liu Y, Tong Z, Shi J, et al. Drug repurposing for next⁃generation combination therapies against multidrug⁃resistant bacteria[J]. Theranostics, 2021,11(10):4910⁃4928. doi: 10.7150/thno.56205.
|